Sangui Biotech International, Inc.
General ticker "SGBI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $111.5K (TTM average)
Sangui Biotech International, Inc. follows the US Stock Market performance with the rate: 18.9%.
Estimated limits based on current volatility of 0.0%: low 0.00$, high 0.00$
Short-term SGBI quotes
Long-term SGBI plot
Financial data
| YTD | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|
| Operating Revenue | $0.07MM | $0.07MM | $0.09MM |
| Operating Expenses | $0.22MM | $0.21MM | $0.18MM |
| Operating Income | $-0.15MM | $-0.14MM | $-0.09MM |
| Non-Operating Income | $-0.05MM | $0.08MM | $-0.06MM |
| Interest Expense | $0.02MM | $0.02MM | $0.00MM |
| R&D Expense | $0.01MM | $0.01MM | $0.00MM |
| Income(Loss) | $-0.20MM | $-0.06MM | $-0.15MM |
| Taxes | $0.03MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-0.24MM | $-0.06MM | $-0.15MM |
| Stockholders Equity | $-0.22MM | $-0.24MM | $-0.38MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $0.13MM | $0.13MM | $0.09MM |
| Operating Cash Flow | $-0.15MM | $-0.14MM | $-0.01MM |
| Financing Cash Flow | $0.16MM | $0.14MM | $0.00MM |
| Earnings Per Share** | $-0.00 | $-0.00 | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.